文献速递心力衰竭与心肌病心律失常

左束支起搏与双心室起搏进行心脏再同步化治疗的随机试验

Randomized Trial of Left Bundle Branch vs Biventricular Pacing for Cardiac Resynchronization Therapy.
PubMed 文献 · J Am Coll Cardiol · 2022-01-01

这项前瞻性随机试验比较左束支起搏(LBBP)与双心室起搏(BiVP)在非缺血性心肌病合并左束支传导阻滞心衰患者中的疗效,共40例患者完成6个月随访。意向治疗分析显示LBBP-CRT在6个月时LVEF改善显著优于BiVP-CRT(平均差5.6%,95%CI 0.3-10.9,P=0.039),左室收缩末期容积和NT-proBNP降低幅度也更大。

要点

  • LBBP-CRT较BiVP-CRT显著提高6个月LVEF改善幅度。
  • LBBP-CRT在左室收缩末期容积和NT-proBNP降低上可能更优。
  • 两组NYHA分级、6分钟步行距离、QRS时限及CRT反应率无显著差异。

核心结论

  • 在非缺血性心肌病合并左束支传导阻滞的心衰患者中,LBBP-CRT的LVEF改善优于BiVP-CRT。

研究设计与样本

  • 前瞻性随机试验,纳入40例非缺血性心肌病合并左束支传导阻滞患者,预设6个月随访。
  • 允许LBBP或BiVP失败时交叉,LBBP-CRT组交叉率10%,BiVP-CRT组交叉率20%。

主要发现

  • 意向治疗分析显示6个月时LBBP-CRT组LVEF改善较BiVP-CRT组平均高5.6%(95%CI 0.3-10.9,P=0.039)。
  • LBBP-CRT组左室收缩末期容积较BiVP-CRT组多降低24.97 mL(95%CI -49.58至-0.36 mL)。
  • LBBP-CRT组NT-proBNP较BiVP-CRT组多降低1071.80 pg/mL(95%CI -2099.40至-44.20 pg/mL)。
  • 两组NYHA分级、6分钟步行距离、QRS时限及CRT反应率的变化相当。

临床怎么用

  • 对于非缺血性心肌病合并左束支传导阻滞、LVEF降低的心衰患者,LBBP-CRT可作为BiVP-CRT的潜在替代选择。

局限性

  • 样本量较小(共40例),随访时间仅6个月,结论需更大规模及更长随访验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Left bundle branch pacing (LBBP) is the most rapidly growing conduction system pacing technique that is capable of correcting intrinsic left bundle branch block (LBBB). As such, it is potentially an optimal alternative to cardiac resynchronization therapy (CRT) with biventricular pacing (BiVP). OBJECTIVES: The authors sought to compare the efficacy of LBBP-CRT with BiVP-CRT in patients with heart failure and reduced left ventricular ejection fraction (LVEF). METHODS: This is a prospective, randomized trial of patients with nonischemic cardiomyopathy and LBBB with 6-month preplanned follow-up. Crossovers were allowed if LBBP or BiVP were unsuccessful. The primary endpoint was the difference in LVEF improvement between 2 groups. The secondary endpoints included changes in echocardiographic measurements, N-terminal pro-B-type natriuretic peptide (NT-proBNP), New York Heart Association functional class, 6-minute walk distance, QRS duration, and CRT response. RESULTS: The study included 40 consecutive patients (20 males, mean age 63.7 years, LVEF 29.7% ± 5.6%). Crossovers occurred in 10% of LBBP-CRT and 20% of BiVP-CRT. All patients completed follow-up. Intention-to-treat analysis showed significantly higher LVEF improvement at 6 months after LBBP-CRT than BiVP-CRT (mean difference: 5.6%; 95% CI: 0.3-10.9; P = 0.039). LBBP-CRT also appeared to have greater reductions in left ventricular end-systolic volume (-24.97 mL; 95% CI: -49.58 to -0.36 mL) and NT-proBNP (-1,071.80 pg/mL; 95% CI: -2,099.40 to -44.20 pg/mL), and comparable changes in New York Heart Association functional class, 6-minute walk distance, QRS duration, and rates of CRT response compared with BiVP-CRT. CONCLUSIONS: LBBP-CRT demonstrated greater LVEF improvement than BiVP-CRT in heart failure patients with nonischemic cardiomyopathy and LBBB. (Left Bundle Branch Pacing Versus Biventricular Pacing for Cardiac Resynchronization Therapy [LBBP-RESYNC]; NCT04110431).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Wang Y, Zhu H, Hou X, et al. Randomized Trial of Left Bundle Branch vs Biventricular Pacing for Cardiac Resynchronization Therapy. J Am Coll Cardiol. 2022. PMID: 36137670. doi:10.1016/j.jacc.2022.07.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。